Quantitative assessment of BRAF V600 mutant circulating cell-free tumor DNA as a tool for therapeutic monitoring in metastatic melanoma patients treated with BRAF/MEK inhibitors - Concepedia

Concepedia

Publication | Open Access

Quantitative assessment of BRAF V600 mutant circulating cell-free tumor DNA as a tool for therapeutic monitoring in metastatic melanoma patients treated with BRAF/MEK inhibitors

DOI Full Paper Access

136

Citations

35

References

2016

Year

Max Schreuer, Geert Meersseman, Sari Van Den Herrewegen, Yanina Jansen, Inès Chevolet, Ambre Bott, Sofie Wilgenhof, Teofila Seremet, Bart Jacobs, Ronald Buyl,

Journal of Translational Medicine

Abstract

Quantitative analysis of BRAF V600mut ctDNA in plasma has unique features as a monitoring tool during treatment with BRAF/MEK inhibitors. Its potential as an early predictor of acquired resistance deserves further evaluation.

References

	Year	Citations

Page 1